Funding · Company
Claris Biotherapeutics, Inc.
Half Moon Bay, CABiotech & Pharma
Claris Biotherapeutics, Inc. of Half Moon Bay, CA has disclosed $100M across 2 Form D offerings filed with the SEC between Oct 24, 2023 and Aug 12, 2026.
$100M
Total disclosed
2
Form D offerings
2018
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$56M
Form D · Aug 12, 2026 ↗
Q3 2026
· 1 amendment, first filed Aug 7, 2026
· target $121M
$44M
Form D · Oct 24, 2023 ↗
Q4 2023
· 1 amendment, first filed Jul 14, 2021
Filing details
HeadquartersHalf Moon Bay, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2018SEC CIK0001809726Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →